Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease-Reference-Cited by-同舟云学术

Plasma interleukin-41 serves as a potential diagnostic biomarker for Kawasaki disease

Published:2023-05 Issue: Volume:147 Page:104478
ISSN:0026-2862
Container-title:Microvascular Research
language:en
Short-container-title:Microvascular Research

Author:

Cai Xiaohong,Li Kan,Li Mingcai,Lu Yanbo,Wu Junhua,Qiu Haiyan,Li Yan

Publisher

Elsevier BV

Subject

Cell Biology,Cardiology and Cardiovascular Medicine,Biochemistry

Reference24 articles.

1. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome;Bordea;Physiol. Res.,2022

2. The novel cytokine Metrnl/IL-41 is elevated in psoriatic arthritis synovium and inducible from both entheseal and synovial fibroblasts;Bridgewood;Clin. Immunol.,2019

3. JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease;Fukazawa;Circ J.,2020

4. The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease;Gordon;JACC Cardiovasc. Interv.,2016

5. Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease;Han;Medicine (Baltimore),2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homotherapy for heteropathy: Interleukin‐41 and its biological functions;Immunology;2024-04-09

2. Serum interleukin-41 concentrations are decreased in women with rheumatoid arthritis and are not affected by menopausal status, disease activity, or medication;Revista Colombiana de Reumatología;2024-02

3. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease;International Immunopharmacology;2023-09